The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 29, 2022

Filed:

Jun. 07, 2018
Applicant:

The Scripps Research Institute, La Jolla, CA (US);

Inventors:

Ryan Shenvi, San Diego, CA (US);

Jeremy Roach, San Diego, CA (US);

Yusuke Sasano, Sendai, JP;

Laura Bohn, Jupiter, FL (US);

Cullen Schmid, Cambridge, MA (US);

Assignee:

The Scripps Research Institute, La Jolla, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 407/04 (2006.01); A61P 17/04 (2006.01); C07C 69/757 (2006.01); C07D 307/54 (2006.01);
U.S. Cl.
CPC ...
C07D 407/04 (2013.01); A61P 17/04 (2018.01); C07C 69/757 (2013.01); C07D 307/54 (2013.01);
Abstract

The invention provides 20-nor-salvinorin A, an analog of the kappa-opioid agonist salvinorin A. The 20-nor-salvinorin A is an active kappa-opioid modulator and can be used for treatment of medical conditions wherein modulation of the kappa-opioid receptor is medically indicated, such as pain, pruritis, depression, or inflammation, or conditions implicating perception and consciousness. 20-nor-salvinorin A can be less additive when used in treatment compared to a mu-opioid receptor agonist, and 20-nor-salvinorin A is more stable in vivo than is parent compound salvinorin A. The invention further provides synthetic intermediates and procedures for preparation of 20-nor-salvinorin A.


Find Patent Forward Citations

Loading…